Anneli Kojo

589 total citations
16 papers, 519 citations indexed

About

Anneli Kojo is a scholar working on Pharmacology, Biochemistry and Oncology. According to data from OpenAlex, Anneli Kojo has authored 16 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 7 papers in Biochemistry and 4 papers in Oncology. Recurrent topics in Anneli Kojo's work include Pharmacogenetics and Drug Metabolism (10 papers), Eicosanoids and Hypertension Pharmacology (7 papers) and Drug Transport and Resistance Mechanisms (4 papers). Anneli Kojo is often cited by papers focused on Pharmacogenetics and Drug Metabolism (10 papers), Eicosanoids and Hypertension Pharmacology (7 papers) and Drug Transport and Resistance Mechanisms (4 papers). Anneli Kojo collaborates with scholars based in Finland and Germany. Anneli Kojo's co-authors include Paavo Honkakoski, Olavi Pelkonen, Arja Rautio, Markku Pasanen, H Hanhijärvi, Markku Ylinen, M. Lang, Hannu Raunio, Pekka Peura and Veli‐Matti Kosma and has published in prestigious journals such as Hepatology, Biochemical Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Anneli Kojo

16 papers receiving 498 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anneli Kojo Finland	12	298	165	123	91	74	16	519
Summer Jolley United States	10	434 1.5×	167 1.0×	272 2.2×	61 0.7×	66 0.9×	11	825
B.H. Thomas United Kingdom	13	185 0.6×	108 0.7×	119 1.0×	44 0.5×	51 0.7×	53	502
S S Lau United States	16	225 0.8×	526 3.2×	135 1.1×	51 0.6×	76 1.0×	28	958
Ulrike Pabel Germany	11	280 0.9×	314 1.9×	88 0.7×	22 0.2×	107 1.4×	19	706
S. E. Clarke United Kingdom	12	597 2.0×	236 1.4×	317 2.6×	17 0.2×	31 0.4×	14	961
Ghada Abdelhamid Canada	15	108 0.4×	149 0.9×	63 0.5×	26 0.3×	51 0.7×	28	530
Zeen Tong United States	15	207 0.7×	397 2.4×	139 1.1×	17 0.2×	171 2.3×	35	846
W. Griffith Humphreys United States	13	183 0.6×	410 2.5×	93 0.8×	15 0.2×	96 1.3×	17	849
Jillian Ross United Kingdom	6	268 0.9×	132 0.8×	137 1.1×	14 0.2×	31 0.4×	7	426
D. Reichert Germany	12	166 0.6×	173 1.0×	57 0.5×	31 0.3×	204 2.8×	21	730

Countries citing papers authored by Anneli Kojo

Since Specialization

Citations

This map shows the geographic impact of Anneli Kojo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anneli Kojo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anneli Kojo more than expected).

Fields of papers citing papers by Anneli Kojo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anneli Kojo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anneli Kojo. The network helps show where Anneli Kojo may publish in the future.

Co-authorship network of co-authors of Anneli Kojo

This figure shows the co-authorship network connecting the top 25 collaborators of Anneli Kojo. A scholar is included among the top collaborators of Anneli Kojo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anneli Kojo. Anneli Kojo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Kojo, Anneli, et al.. (1998). Induction of CYP2A5 by pyrazole and its derivatives in mouse primary hepatocytes. Archives of Toxicology. 72(6). 336–341. 12 indexed citations

Kojo, Anneli, et al.. (1996). Distinct responses of mouse hepatic CYP enzymes to corn oil and peroxisome proliferators. Biochemical Pharmacology. 51(9). 1137–1143. 7 indexed citations

Stenbäck, Frej, et al.. (1996). Regenerative changes in hepatic morphology and enhanced expression of CYP 2B10 and CYP 3A during daily administration of cocaine. Hepatology. 23(3). 515–523. 39 indexed citations

Pennanen, S., et al.. (1996). CYP enzymes catalyze the formation of a terminal olefin from 2-ethylhexanoic acid in rat and human liver. Human & Experimental Toxicology. 15(5). 435–442. 6 indexed citations

Pasanen, Markku, Susanne Lang, Anneli Kojo, & Veli‐Matti Kosma. (1995). Effects of Simulated Nuclear Fuel Particles on the Histopathology and CYP Enzymes in the Rat Lung and Liver. Environmental Research. 70(2). 126–133. 22 indexed citations

Pelkonen, Olavi, et al.. (1994). Cytochrome P4502A5 Expression and Inducibility by Phenobarbital Is Modulated by cAMP in Mouse Primary Hepatocytes. Biochemical and Biophysical Research Communications. 205(1). 631–637. 40 indexed citations

Honkakoski, Paavo, Anneli Kojo, & M. Lang. (1992). Regulation of the mouse liver cytochrome P450 2B subfamily by sex hormones and phenobarbital. Biochemical Journal. 285(3). 979–983. 68 indexed citations

Rautio, Arja, et al.. (1992). Interindividual variability of coumarin 7-hydroxylation in healthy volunteers. Pharmacogenetics. 2(5). 227–233. 136 indexed citations

Honkakoski, Paavo, Anneli Kojo, Lang Ma, & M. Lang. (1992). Regulation of mouse liver P450, 2B subfamily by sex hormones and phenobarbital. 3 indexed citations

10.

Kojo, Anneli, et al.. (1991). Inducibility of P450Coh by pyrazole and its derivatives. Biochemical Pharmacology. 42(9). 1751–1759. 14 indexed citations

11.

Ylinen, Markku, Anneli Kojo, H Hanhijärvi, & Pekka Peura. (1990). Disposition of perfluorooctanoic acid in the rat after single and subchronic administration. Bulletin of Environmental Contamination and Toxicology. 44(1). 46–53. 53 indexed citations

12.

Kojo, Anneli, Paavo Honkakoski, Päivi Järvinen, Olavi Pelkonen, & Matti A. Lang. (1989). Preferential Inhibition of Mouse Hepatic Coumarin 7‐Hydroxylase by Inhibitors of Steroid Metabolizing Monooxygenases. Pharmacology & Toxicology. 65(2). 104–109. 6 indexed citations

13.

Raunio, Hannu, Anneli Kojo, Paavo Honkakoski, et al.. (1988). Mouse hepatic cytochrome p-450 isozyme induction by 1,4-bis[2-(3,5-dichloropyridyloxy)] benzene, pyrazole, and phenobarbital. Biochemical Pharmacology. 37(21). 4141–4147. 38 indexed citations

14.

Honkakoski, Paavo, et al.. (1988). Hepatic mitochondrial coumarin 7-hydroxylase: Comparison with the microsomal enzyme. Archives of Biochemistry and Biophysics. 267(2). 558–567. 25 indexed citations

15.

Hanhijärvi, H, Markku Ylinen, Anneli Kojo, & Veli‐Matti Kosma. (1987). Elimination and Toxicity of Perfluorooctanoic Acid during Subchronic Administration in the Wistar Rat. Pharmacology & Toxicology. 61(1). 66–68. 30 indexed citations

16.

Kojo, Anneli, H Hanhijärvi, Markku Ylinen, & Veli‐Matti Kosma. (1986). Toxicity and Kinetics of Perfluoro-octanoic Acid in the Wistar Rat. Archives of toxicology. Supplement. 9. 465–468. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact